← Open Payments lookup

ELIZABETH MAPLES: Open Payments

NPI 1548298003 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,079 in 115 payments from 15 companies in 2025. Trend: 2023 $162 · 2024 $338 · 2025 $2,079

Food & beverage: $2,079
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$330
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$259
Alkermes, Inc.13$230
ABBVIE INC.17$230
Otsuka America Pharmaceutical, Inc.18$218
Lundbeck LLC10$187
E.R. Squibb & Sons, L.L.C.10$179
Axsome Therapeutics, Inc.8$134
Vanda Pharmaceuticals Inc.6$112
Teva Pharmaceuticals USA, Inc.4$62

Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, ARISTADA, COBENFY, Auvelity, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.